VIM and endothelial dysfunction: A study showed that TSG (50, 100 μM) protected human umbilical vein endothelial cells (HUVECs) from oxidized low-density lipoprotein (oxLDL)-induced endothelial dysfunction by inhibiting the expression and cleavage of vimentin, and the expression of adhesion molecules and their co-localization with vimentin (Yao et al., 2014).